Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...
7d
Global Kaposi's Sarcoma Market Accelerates with Rising HIV/AIDS Prevalence and Innovative Treatments
The global Kaposi’s Sarcoma market is expanding due to the HIV/AIDS prevalence, improved oncology infrastructure, and advancements in targeted and immunotherapeutic drugs. Kaposi’s Sarcoma, a tumor ...
Specialized sarcoma centers enhance coordinated care for young adults, although travel and financial barriers persist, Dr. Vinayak Venkataraman stated. Specialized, multidisciplinary care at ...
The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...
Study conducted in a collaboration between MEDSIR and University Hospital Vall d'Hebron to evaluate bexmarilimab plus standard-of-care doxorubicin in a high-unmet-need frontline setting. TURKU, FI / ...
New research from Dartmouth Health and Dartmouth Cancer Center reveals a glowing molecule designed to highlight soft-tissue sarcomas during surgery, paving the way for more precise tumor removal and ...
According to new research, radiation therapy administered before surgery rarely produces favorable responses in patients with ...
Community members packed a local pickleball venue to raise money for a West Fargo man who is battling a rare form of cancer ...
Ewing sarcoma is a malignant type of bone tumor, meaning it is a form of cancer that spreads. According to a 2024 review, Ewing sarcoma is the second most common primary cancerous bone tumor. It ...
Sean Baute welcomes the Sarcoma Foundation of America to the Listens Live! studio to highlight the 2025 Race to Cure Sarcoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results